Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply

Bibliographic Details
Main Authors:	Monson, J, Coyte, D, Kaltsas, G, Jenkins, P, Chew, S, Grossman, AB, Besser, G
Format:	Journal article
Published:	2001

Similar Items

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
by: Florakis, D, et al.
Published: (2000)

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
by: Drake, WM, et al.
Published: (1998)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
by: le Roux, C, et al.
Published: (2002)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
by: Agha, A, et al.
Published: (2007)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
by: Frajese, G, et al.
Published: (2001)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
by: Colson, A, et al.
Published: (2008)

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
by: Chung, T, et al.
Published: (2008)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
by: Jenkins, P, et al.
Published: (2000)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
by: Irene K Oglesby, et al.
Published: (2023-09-01)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
by: Sverrisdóttir, Y, et al.
Published: (2003)

PROLACTINOMAS - REPLY
by: Grossman, A, et al.
Published: (1985)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
by: Kaltsas, G, et al.
Published: (2001)

Uterine leiomyomata in women with acromegaly
by: Kaltsas, G, et al.
Published: (2000)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
by: Isidori, A, et al.
Published: (2003)

The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
by: Kaltsas, G, et al.
Published: (2003)

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
by: Kaltsas, G, et al.
Published: (2003)

Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment.
by: Putignano, P, et al.
Published: (2000)

Growth hormone cut-off post glucagon stimulation test in an Indian cohort of overweight/obese hypopituitary patients for the diagnosis of adult growth hormone deficiency
by: Vijay Sheker Reddy Danda, et al.
Published: (2023-01-01)

Reply to Oreska et al ‘Comment on Geoengineering with seagrasses: is credit due where credit is given?’
by: Sophia C Johannessen, et al.
Published: (2018-01-01)

Reply to Macreadie et al Comment on ‘Geoengineering with seagrasses: is credit due where credit is given?’
by: Sophia C Johannessen, et al.
Published: (2018-01-01)

Growth hormone releasing hormone.
by: Grossman, A, et al.
Published: (1986)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
by: Colson, A, et al.
Published: (2006)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
by: Chung, T, et al.
Published: (2005)

Menstrual irregularity in women with acromegaly.
by: Kaltsas, G, et al.
Published: (1999)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
by: Kaltsas, G, et al.
Published: (1998)

Cholesterol, statins, and mortality - Reply
by: Lewington, S, et al.
Published: (2008)

Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
by: Kaltsas, G, et al.
Published: (2000)

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
by: Tomlinson, J, et al.
Published: (2001)

Reply to comments
by: Dzenovska, D
Published: (2014)

Comments and reply
by: L Brito-Castillo, et al.
Published: (2002-03-01)

Reply to Comments
by: Martin Lenz
Published: (2023-12-01)

Reply to Comments
by: Anders Gustafsson, et al.
Published: (2011-12-01)

Reply to Comments
by: Arun P. Singh
Published: (2016-05-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
by: Korbonits, M, et al.
Published: (1999)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
by: Alexandraki, K, et al.
Published: (2009)

Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
by: Ross, R, et al.
Published: (1986)

Cholesterol, statins, and mortality - Authors' reply
by: Lewington, S, et al.
Published: (2008)

The diagnosis and medical management of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2004)

Children in the mountains - Advice given was too conservative - Reply
by: Pollard, A, et al.
Published: (1998)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
by: Korbonits, M, et al.
Published: (1999)